Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis
Atypical antipsychotic drugs have less extra pyramidal side effects and are more effective to control the clinical manifestations of schizophrenia. However, their use may be associated to a higher incidence of weight gain, dyslipidemia, metabolic syndrome, glucose intolerance and type 2 diabetes mel...
Guardado en:
Autores principales: | , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2009
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001100002 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872009001100002 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720090011000022010-01-13Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisisSapunar Z,JorgeMuñoz N,SergioVásquez A,Tatiana Antipsychotic agents Aripiprazole Diabetes mellitus Clozapine Olanzapine Quetiapine Risperidone Ziprasidone Zotepine Atypical antipsychotic drugs have less extra pyramidal side effects and are more effective to control the clinical manifestations of schizophrenia. However, their use may be associated to a higher incidence of weight gain, dyslipidemia, metabolic syndrome, glucose intolerance and type 2 diabetes mellitus. We performed a systematic literature search to evaluate the risk of type 2 diabetes mellitus incidence associated to the use of atypical antipsychotic drugs, compared to conventional treatment. If users of all types of atypical antipsychotic drugs are compared with users of conventional treatment, no significant differences in the incidence of type 2 diabetes mellitus were observed. If individual drugs are evaluated, clozapine and risperidone are associated with a higher risk of diabetes than haloperidol. Quetiapine is associated with a lower risk of diabetes than conventional treatment. The quality of the evidence found was low; therefore, new studies should been performed.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.137 n.11 20092009-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001100002es10.4067/S0034-98872009001100002 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Antipsychotic agents Aripiprazole Diabetes mellitus Clozapine Olanzapine Quetiapine Risperidone Ziprasidone Zotepine |
spellingShingle |
Antipsychotic agents Aripiprazole Diabetes mellitus Clozapine Olanzapine Quetiapine Risperidone Ziprasidone Zotepine Sapunar Z,Jorge Muñoz N,Sergio Vásquez A,Tatiana Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis |
description |
Atypical antipsychotic drugs have less extra pyramidal side effects and are more effective to control the clinical manifestations of schizophrenia. However, their use may be associated to a higher incidence of weight gain, dyslipidemia, metabolic syndrome, glucose intolerance and type 2 diabetes mellitus. We performed a systematic literature search to evaluate the risk of type 2 diabetes mellitus incidence associated to the use of atypical antipsychotic drugs, compared to conventional treatment. If users of all types of atypical antipsychotic drugs are compared with users of conventional treatment, no significant differences in the incidence of type 2 diabetes mellitus were observed. If individual drugs are evaluated, clozapine and risperidone are associated with a higher risk of diabetes than haloperidol. Quetiapine is associated with a lower risk of diabetes than conventional treatment. The quality of the evidence found was low; therefore, new studies should been performed. |
author |
Sapunar Z,Jorge Muñoz N,Sergio Vásquez A,Tatiana |
author_facet |
Sapunar Z,Jorge Muñoz N,Sergio Vásquez A,Tatiana |
author_sort |
Sapunar Z,Jorge |
title |
Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis |
title_short |
Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis |
title_full |
Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis |
title_fullStr |
Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis |
title_full_unstemmed |
Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis |
title_sort |
comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: revisión sistemática y metaanálisis |
publisher |
Sociedad Médica de Santiago |
publishDate |
2009 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001100002 |
work_keys_str_mv |
AT sapunarzjorge comparaciondelefectodelaterapiaprolongadaconantipsicoticosatipicosoconvencionalesenlaincidenciadediabetesmellitus2revisionsistematicaymetaanalisis AT munoznsergio comparaciondelefectodelaterapiaprolongadaconantipsicoticosatipicosoconvencionalesenlaincidenciadediabetesmellitus2revisionsistematicaymetaanalisis AT vasquezatatiana comparaciondelefectodelaterapiaprolongadaconantipsicoticosatipicosoconvencionalesenlaincidenciadediabetesmellitus2revisionsistematicaymetaanalisis |
_version_ |
1718436471792205824 |